𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9009 A meta-analysis of four randomized phase II/III trials adding cetuximab to platinum-based chemotherapy as 1st-line treatment in patients with non-small cell lung cancer (NSCLC)

✍ Scribed by Pujol, J.; Lynch, T.J.; Rosell, R.; Butts, C.A.; Shepherd, F.A.; Thatcher, N.; Vansteenkiste, J.; Manegold, C.; Groos, J.; Pirker, R.


Book ID
122980454
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
50 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES